Latest filing published 12 Apr 2013 for CALMARE THERAPEUTICS Inc.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Richard D. Hornidge is a declared insider of CALMARE THERAPEUTICS Inc, with filings sourced from SEC (Form 4). We count 17 filings; the first trade dates from 20 March 2007 and the latest from 21 March 2013.
On the market, this insider has only ever bought: 10 purchases, €41k in total. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 7 share grants.
In size, the median ticket on the buying side is €1,763.
The latest filing, published on 12 April 2013, reports a share grant in CALMARE THERAPEUTICS Inc. The last insider purchase was made public on 27 September 2012, 5,140 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations